Evidence map›Paper›PMID 38398550›Full record

ArticleMolecules (Basel, Switzerland)2024

Chuntao Xu, Jiawei Dai, Hongxia Ai, Weian Du, Hongbing Ji

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. The Extract ofCurrent issues in molecular biology · 2025
    Article
  12. Advances in Research on Concentrated Growth Factor Applications for Androgenetic Alopecia Treatment: A Review.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  13. Article
  14. Article
  15. Hair Growth-Promoting Effect ofInternational journal of molecular sciences · 2024
    Article
  16. Antioxidant Properties ofMolecules (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chuntao XuSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China.ORCID 0000-0002-6189-0102
Jiawei DaiSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China.
Hongxia AiGuangdong Institute of Modern Agricultural Equipment, Guangzhou 510145, China.
Weian DuGuangdong Homy Genetics Ltd., Foshan 528000, China.ORCID 0000-0002-5202-2995
Hongbing JiSchool of Chemistry and Chemical Engineering, Guangxi University, Nanning 530004, China.ORCID 0000-0003-1684-9925
Guangxi University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

β-Nicotinamide mononucleotide (NMN) has shown promising effects on intestinal health, and it is extensively applied as an anti-aging and Alzheimer's disease therapeutic, due to its medicinal properties. The effects of NMN on the growth of mouse hair were observed after hair removal. The results indicated that NMN can reverse the state of hair follicle atrophy, hair thinning, and hair sparsity induced by dihydrotestosterone (DHT), compared to that of minoxidil. In addition, the action mechanisms of NMN promoting hair growth in cultured human dermal papilla cells (HDPCs) treated with DHT were investigated in detail. The incubation of HDPCs with DHT led to a decrease in cell viability and the release of inflammatory mediators, including interleukin-6 (IL-6), interleukin-1Beta (IL-1β) and tumor necrosis factor Alpha (TNF-α). It was found that NMN can significantly lower the release of inflammatory factors induced by DHT in HDPCs. HDPCs cells are protected from oxidative stress damage by NMN, which inhibits the NF-κB p65 inflammatory signaling pathway. Moreover, the levels of androgen receptor (AR), dickkopf-1 (DKK-1), and β-catenin in the HDPCs were assessed using PCR, indicating that NMN can significantly enhance the expression of VEGF, reduced IL-6 levels and suppress the expression of AR and DKK-1, and notably increase β-catenin expression in DHT-induced HDPCs.

Indexed as

beta CateninNicotinamide MononucleotideAnimalsCell ProliferationDihydrotestosteroneHairHair FollicleHumansInterleukin-6MiceOxidative Stressbeta CateninDihydrotestosteroneInterleukin-6Nicotinamide Mononucleotideandrogenetic alopeciadermal papilla cellminoxidilβ-Nicotinamide mononucleotide (NMN)

Identifiers

PMID38398550
PMCPMC10893548
OpenAlexW4391683123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.